Impact of BRCA1 mutation status on the therapeutic efficacy of CDK4/6 inhibitors in triple negative breast cancer | AVESİS

Bezmialem Vakıf University Research Information System

Impact of BRCA1 mutation status on the therapeutic efficacy of CDK4/6 inhibitors in triple negative breast cancer

Copy For Citation

GÜNEY ESKİLER G., ÖZMAN Z.

European Human Genetics Virtual Conference 2020, 6 - 09 June 2020

Publication Type: Conference Paper / Summary Text
Bezmialem Vakıf University Affiliated: Yes